1LLY:BIT
Eli Lilly And Co
1.017,40 €
arrow_downward
-0,57%(-5,80) 1D
2 okt, 17:29:23 GMT+2 · EUR
search
Bütün simvollar
| Simvol | Qiymət | Dəyişiklik | % Dəyişiklik |
|---|
insights_auto1LLY üçün ən vacib statistik məlumatlar yaradılır...
Açın
1.023,60 €
Yüksək
1.031,00 €
Aşağı
1.016,00 €
Bazar kapitalizasiyası
1,09 trln
Ortalama həcm
382,00
Həcm
492,00
52 həftəlik ən yüksək
1.106,80 €
52 həftəlik ən aşağı
640,70 €
İşçilərin sayı
50K
Açın
1.023,60 €
Yüksək
1.031,00 €
Aşağı
1.016,00 €
Bazar kapitalizasiyası
1,09 trln
Ortalama həcm
382,00
Həcm
492,00
52 həftəlik ən yüksək
1.106,80 €
52 həftəlik ən aşağı
640,70 €
İşçilərin sayı
50K
Xəbər materialları
Veb mənbələri və xəbər partnyorlarından
Yahoo Finance
·
5 saat öncə
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
GuruFocus
·
6 saat öncə
Lilly Stock Rises as $870 Million Gate Deal Adds One Target
24/7 Wall St.
·
8 saat öncə
Prediction: LLY Has Another Massive Growth Opportunity Beyond Weight Loss
Profil
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Eli Lilly And Co haqqında
Baş İcraçı DirektorDavid A. Ricks
İşçilər50K
Təsis Tarixi1876
Baş Ofisİndianapolis, İndiana, Amerika Birləşmiş Ştatları
SektorPharmaceutical industry
Veb-saytlilly.com